Literature DB >> 10369153

Psychotic relapse and maintenance therapy in paranoid schizophrenia: a 15 year follow up.

T Ohmori1, K Ito, T Abekawa, T Koyama.   

Abstract

In spite of numerous reports on a 1 to 2 year maintenance neuroleptic treatment of schizophrenia, there is little systematic information on decade-long maintenance therapy. We conducted a retrospective study in fifty outpatients with paranoid schizophrenia who have been seen at our clinic for a duration of 15 years or more since their first psychotic episodes. Relapse rate within 2, 5, 10, and 15 years from remission of the first psychotic episode were 52, 60, 86, and 90%, respectively. However, the incidence of relapse decreased with time. This decrease was accounted for by the decrease of relapse observed when off drug. Conversely, the incidence of relapse occurred on drug remained unchanged. The average maintenance dose 15 years after remission of the first psychotic episode was 5.41 +/- 7.28 mg/d (haloperidol equivalents: mean +/- SD). The maintenance dose correlated significantly with the number of relapses and total duration of psychotic episodes. These results suggest that maintenance treatment remained effective for decades, although it did not ameliorate the liability to relapse itself. Repeated relapse may be associated with requirement for a higher neuroleptic dose for relapse prevention.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10369153     DOI: 10.1007/s004060050069

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  5 in total

Review 1.  Stimulant-induced psychosis and schizophrenia: the role of sensitization.

Authors:  Hiroshi Ujike
Journal:  Curr Psychiatry Rep       Date:  2002-06       Impact factor: 5.285

2.  Direct costs of schizophrenia in Italian community psychiatric services.

Authors:  L Garattini; C Rossi; F Tediosi; C Cornaggia; G Covelli; C Barbui; F Parazzini
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 3.  Are structural brain changes in schizophrenia related to antipsychotic medication? A narrative review of the evidence from a clinical perspective.

Authors:  Stephen M Lawrie
Journal:  Ther Adv Psychopharmacol       Date:  2018-06-15

4.  High relapse rate and poor medication adherence in the Chinese population with schizophrenia: results from an observational survey in the People's Republic of China.

Authors:  Jingbo Xiao; Weifeng Mi; Lingzhi Li; Ying Shi; Hongyan Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2015-05-08       Impact factor: 2.570

5.  Predicting rehospitalization in patients treated with antipsychotics: a prospective observational study.

Authors:  Heshu Abdullah-Koolmees; Helga Gardarsdottir; Lotte A Minnema; Kamjar Elmi; Lennart J Stoker; Judith Vuyk; Laurette E Goedhard; Toine C G Egberts; Eibert R Heerdink
Journal:  Ther Adv Psychopharmacol       Date:  2018-03-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.